These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 3136429
1. [Sensitivity of 7 mycobacterial species to new quinolones]. Gevaudan MJ, Mallet MN, Gulian C, Terriou P, Lagier P, de Micco P. Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429 [Abstract] [Full Text] [Related]
4. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria. Young LS, Berlin OG, Inderlied CB. Am J Med; 1987 Apr 27; 82(4A):23-6. PubMed ID: 3107379 [Abstract] [Full Text] [Related]
5. [In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria]. Saito H, Sato K, Tomioka H, Watanabe T. Kekkaku; 1987 May 27; 62(5):287-94. PubMed ID: 3114537 [No Abstract] [Full Text] [Related]
7. [Antibiogram of mycobacteria for erythromycin, tetracycline and cotrimoxazole]. Demoulin L, Médard M, Kellens J. Pathol Biol (Paris); 1983 Mar 27; 31(3):195-7. PubMed ID: 6343976 [Abstract] [Full Text] [Related]
8. Comparative in-vitro activity of five fluoroquinolones against mycobacteria. Davies S, Sparham PD, Spencer RC. J Antimicrob Chemother; 1987 May 27; 19(5):605-9. PubMed ID: 3112094 [Abstract] [Full Text] [Related]
9. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus]. Zuccarelli M, Simeon de Buochberg M, Maillols M, Armynot du Chatelet AM, Attisso MA. Pathol Biol (Paris); 1988 May 27; 36(5):403-9. PubMed ID: 3136422 [Abstract] [Full Text] [Related]
10. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates. Periti P, Mazzei T, Nicoletti P. Chemioterapia; 1987 Apr 27; 6(2):75-8. PubMed ID: 3474081 [Abstract] [Full Text] [Related]
16. [Comparison of in vitro growth-inhibitory activities of ofloxacin, ciprofloxacin and norfloxacin against various species of mycobacteria (comparison of organ concentrations and blood concentrations in mice)]. Tsukamura M, Mizuno S, Toyama H. Kekkaku; 1986 Sep 27; 61(9):453-9. PubMed ID: 3467134 [No Abstract] [Full Text] [Related]
17. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans]. Renaudin H, Quentin C, de Barbeyrac B, Bebear C. Pathol Biol (Paris); 1988 May 27; 36(5):496-9. PubMed ID: 3136430 [Abstract] [Full Text] [Related]
18. [In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin]. Soussy CJ, Deforges L, Le Van Thoi J, Duval J. Pathol Biol (Paris); 1987 Jun 27; 35(5 Pt 2):759-67. PubMed ID: 3309811 [Abstract] [Full Text] [Related]
19. [In vitro antibacterial activity of piperacillin/quinolone combinations]. Soussy CJ, Leclercq R, Duval J. Pathol Biol (Paris); 1988 May 27; 36(5):357-60. PubMed ID: 3136421 [Abstract] [Full Text] [Related]
20. [In vitro comparative activity of norfloxacin in the comparison of pathogenic bacteria of the urinary tract]. Carlone NA, Cuffini AM, Tullio V, Savoia D, Cavallo GP. G Batteriol Virol Immunol; 1986 May 27; 79(1-6):85-97. PubMed ID: 3479370 [Abstract] [Full Text] [Related] Page: [Next] [New Search]